AOD-9604vsLiraglutide
AOD-9604 vs Liraglutide — independent comparison of uses, administration, pricing across providers, and key differences. Last reviewed April 21, 2026.
Quick Verdict
Based on clinical evidence and real patient data
A modified fragment (amino acids 176-191) of human growth hormone designed to stimulate fat metabolism without the growth-promoting effects of full HGH. Studied as a targeted fat-loss peptide.
A GLP-1 receptor agonist administered daily for chronic weight management. FDA-approved as Saxenda for obesity and as Victoza for type 2 diabetes. One of the first GLP-1 medications widely used for weight loss before semaglutide.
Best choice depends on your insurance, budget, and treatment history.Take the quiz to get a personalized recommendation.
AOD-9604 vs Liraglutide: At a Glance
Full comparison across all key factors.
| Factor | AOD-9604 | Liraglutide |
|---|---|---|
| Category | weight-loss | weight-loss |
| Also Known As | Anti-Obesity Drug 9604 | Saxenda, Victoza |
| Administration | Subcutaneous injection | Subcutaneous injection (daily) |
| Prescription | Required | Required |
| Providers | 4 providers | 4 providers |
| Common Uses |
|
|
Data sourced from FDA prescribing information and peer-reviewed clinical trials. Prices reflect telehealth platform costs as of April 21, 2026. See our methodology.
Pricing by Provider
3 providers offer both AOD-9604 and Liraglutide.
| Provider | AOD-9604 | Liraglutide | Consultation | Lab Testing |
|---|---|---|---|---|
| $160/monthly | $220/monthly | Video Telehealth | Yes | |
| $185/monthly | $250/monthly | Video Telehealth | Yes | |
| $150/monthly | $200/monthly | Video Telehealth | No | |
| Not offered | $299/monthly | Video Telehealth | Yes | |
| $220/monthly | Not offered | Video Telehealth | Yes |
Key Differences
AOD-9604
A modified fragment (amino acids 176-191) of human growth hormone designed to stimulate fat metabolism without the growth-promoting effects of full HGH. Studied as a targeted fat-loss peptide.
Liraglutide
A GLP-1 receptor agonist administered daily for chronic weight management. FDA-approved as Saxenda for obesity and as Victoza for type 2 diabetes. One of the first GLP-1 medications widely used for weight loss before semaglutide.
Which Is Right for You?
Choose AOD-9604if…
- You want a weight-loss medication
- You prefer subcutaneous injection administration
- 4 providers available on our platform
- Your primary goal is fat metabolism
- Your primary goal is body composition
Choose Liraglutideif…
- You want a weight-loss medication
- You prefer subcutaneous injection (daily) administration
- 4 providers available on our platform
- Your primary goal is weight loss
- Your primary goal is appetite suppression
Frequently Asked Questions
What is the difference between AOD-9604 and Liraglutide?
Which is cheaper, AOD-9604 or Liraglutide?
Can I switch from AOD-9604 to Liraglutide?
Medical Disclaimer
This comparison is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication. Individual results may vary. The information presented reflects publicly available data and may not account for your specific health situation.
Related Guides
AOD-9604 for Weight Loss: Telehealth Providers Guide 2026
Read guide →Generic Liraglutide (Saxenda Generic): The Budget GLP-1 Nobody's Talking About
Generic liraglutide from Teva is the first generic GLP-1 for weight loss. At ~$230/month, is it a viable budget alternative to semaglutide and orforglipron? Complete pricing and comparison guide.
Read guide →